ASHISH JAIN, et al. “CONSTITUTIVELY ACTIVATED TYROSINE KINASE INHIBITOR DRUG DESIGN: HOMOLOGY MODELING AND DOCKING STUDIES ON CHRONIC MYELOGENOUS LEUKEMIA BCR-ABL FUSION PROTEIN”. International Journal of Pharma and Bio Sciences, vol. 6, no. 2, June 2015, pp. 1215-2, https://ijpbs.net/index.php/journal/article/view/4340.